Conrig Pharma
Jyderup
About Conrig Pharma
Conrig Pharma will reposition drug molecules with attractive safety and efficacy profiles through simple modifications and reformulations to provide fast development of new treatments of illnesses. Initial focus will be on a development of a new drug for oral treatment of atopic dermatitis (a type of eczema).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Mar 2013)
- Website: conrigpharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/conrig-pharma-915491 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.